1. Home
  2. INTZ vs ALLR Comparison

INTZ vs ALLR Comparison

Compare INTZ & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intrusion Inc.

INTZ

Intrusion Inc.

HOLD

Current Price

$1.12

Market Cap

21.3M

ML Signal

HOLD

Logo Allarity Therapeutics Inc.

ALLR

Allarity Therapeutics Inc.

HOLD

Current Price

$1.07

Market Cap

19.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INTZ
ALLR
Founded
1983
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.3M
19.3M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
INTZ
ALLR
Price
$1.12
$1.07
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$7.25
$9.50
AVG Volume (30 Days)
139.9K
177.3K
Earning Date
04-28-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
85.78
N/A
EPS
N/A
N/A
Revenue
$5,771,000.00
N/A
Revenue This Year
$35.44
N/A
Revenue Next Year
$23.57
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.85
N/A
52 Week Low
$0.75
$0.61
52 Week High
$2.64
$2.35

Technical Indicators

Market Signals
Indicator
INTZ
ALLR
Relative Strength Index (RSI) 52.97 46.40
Support Level $0.81 $0.99
Resistance Level $1.17 $1.14
Average True Range (ATR) 0.11 0.12
MACD 0.01 -0.01
Stochastic Oscillator 42.35 25.79

Price Performance

Historical Comparison
INTZ
ALLR

About INTZ Intrusion Inc.

Intrusion Inc is a cybersecurity company based in Plano, Texas. The group offers customers to access its threat intelligence database containing the historical data, known associations, and reputational behavior of Internet Protocol (IP) addresses. The company's product consists of On-Premise Network Protection, Cyber Threat Consulting, Cloud Network Security, and Endpoint Protection. Its solutions are INTRUSION Shield, INTRUSION TraceCop, and INTRUSION Savant. Its end-user customers include the U.S. federal government, state and local government entities, large and diversified conglomerates, and manufacturing entities.

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.

Share on Social Networks: